Jazz Pharmaceuticals (JAZZ) Operating Income (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.24% |
| Dec 31, 2025 | 342.60% |
| Sep 30, 2025 | 108.38% |
| Jun 30, 2025 | -1,127.89% |
| Mar 31, 2025 | -129.30% |
| Dec 31, 2024 | -26.69% |
| Sep 30, 2024 | 30.47% |
| Jun 30, 2024 | 201.24% |
| Mar 31, 2024 | -45.95% |
| Dec 31, 2023 | -28.94% |
| Sep 30, 2023 | 9.36% |
| Jun 30, 2023 | 25.05% |
| Mar 31, 2023 | 147.86% |
| Dec 31, 2022 | -1,163.63% |
| Sep 30, 2022 | -71.05% |
| Jun 30, 2022 | -2.29% |
| Mar 31, 2022 | 77.30% |
| Dec 31, 2021 | 74.06% |
| Sep 30, 2021 | 140.77% |
| Jun 30, 2021 | -142.93% |
| Mar 31, 2021 | -6.51% |
| Dec 31, 2020 | -11.62% |
| Sep 30, 2020 | -0.97% |
| Jun 30, 2020 | 204.46% |
| Mar 31, 2020 | -409.70% |
| Dec 31, 2019 | -53.99% |
| Sep 30, 2019 | -34.84% |
| Jun 30, 2019 | 52.74% |
| Mar 31, 2019 | -27.73% |
| Dec 31, 2018 | -1.97% |
| Sep 30, 2018 | 23.22% |
| Jun 30, 2018 | 74.47% |
| Mar 31, 2018 | -37.82% |
| Dec 31, 2017 | 63.33% |
| Sep 30, 2017 | -47.62% |
| Jun 30, 2017 | 21.23% |
| Mar 31, 2017 | -17.74% |
| Dec 31, 2016 | 21.47% |
| Sep 30, 2016 | -19.25% |
| Jun 30, 2016 | 39.26% |
| Mar 31, 2016 | 13.63% |
| Dec 31, 2015 | -18.93% |
| Sep 30, 2015 | -14.20% |
| Jun 30, 2015 | 31.30% |
| Mar 31, 2015 | -10.13% |
| Dec 31, 2014 | 123.86% |
| Sep 30, 2014 | -21.88% |
| Jun 30, 2014 | 211.45% |
| Sep 30, 2013 | 30.49% |
| Jun 30, 2013 | 13.02% |
| Mar 31, 2013 | 1.20% |
| Dec 31, 2012 | 21.84% |
| Sep 30, 2012 | 40.26% |
| Jun 30, 2012 | 10.32% |
| Mar 31, 2012 | -5.11% |
| Dec 31, 2011 | 11.75% |
| Sep 30, 2011 | -0.46% |
| Jun 30, 2011 | 49.79% |
| Mar 31, 2011 | -11.48% |
| Dec 31, 2010 | 76.80% |
| Sep 30, 2010 | 36.49% |